Evidence map›Paper›PMID 35958821›Full record

ArticleBioMed research international2022

IgA-Type Enterovirus Antibodies Are Increased among Adults and Children with Recently Diagnosed Type 1 Diabetes.

Kristi Alnek, Ija Talja, Brita Laht, Kaja Metsküla, Maire Mandel, Ingrid Reppo, Maire Lubi, Raivo Uibo

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kristi AlnekDepartment of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.ORCID https://orcid.org/0000-0001-7774-2908
Ija TaljaDepartment of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.
Brita LahtDepartment of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.
Kaja MetskülaDepartment of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.
Maire MandelDepartment of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.
Ingrid ReppoDepartment of Internal Medicine, Institute of Clinical Medicine, University of Tartu, 8 L. Puusepa, Tartu 50406, Estonia.
Maire LubiDepartment of Internal Medicine, Institute of Clinical Medicine, University of Tartu, 8 L. Puusepa, Tartu 50406, Estonia.
Raivo UiboDepartment of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.ORCID https://orcid.org/0000-0002-2298-1300
University of Tartu · EETartu University Hospital · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enteroviruses (EV) are among the leading environmental triggers of childhood-onset type 1 diabetes (T1D). Our aim was to determine the prevalence of antibodies against EV and their association with T1D in different age groups (

Indexed as

Diabetes Mellitus, Type 1EnterovirusEnterovirus InfectionsAntibodies, ViralAntigens, ViralAutoantibodiesChildHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MProtein Tyrosine Phosphatase, Non-Receptor Type 22Young AdultAntibodies, ViralAntigens, ViralAutoantibodiesImmunoglobulin AImmunoglobulin GImmunoglobulin MProtein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, human

Identifiers

PMID35958821
PMCPMC9357813
OpenAlexW4289132178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.